Navigation Links
22 of America's most promising scientists selected as Pew Biomedical Scholars
Date:6/13/2012

PHILADELPHIA Twenty-two of the nation's most innovative young researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The Scholars join a prestigious community that includes Nobel Prize winners, MacArthur Fellows, and recipients of the Albert Lasker Medical Research Award.

"During these challenging budgetary times when traditional sources of funding are becoming even harder for scientists to obtain, we are proud to back our country's most promising scientists," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts. "This funding comes at points in the Scholars' professional lives when they often are the most innovative. While this program is a bold investment for us, it has paid incalculable dividends due to our Scholars' record of producing groundbreaking research." The new class of scholars is exploring a range of human health issues from antibiotic-resistant infections to liver disease and cancer.

Launched in 1985, the Pew Scholars Program in the Biomedical Sciences identifies and invests in talented researchers in medicine or biomedical sciences. In that time, over 500 Pew Scholars have received more than $130 million in funding. By backing them early in their careers, this program enables our most promising scientists to take calculated risks and follow unanticipated leads to advance human health. "Giving young scientists the means and the confidence to pursue outside-the-box research is vital to the advancement of biomedical science," said Craig C. Mello, Ph.D., a 1995 Pew Scholar and a 2006 Nobel Laureate in Physiology or Medicine. "The Pew Scholars Program in the Biomedical Sciences was a critical step in my career, and as Chair of the national advisory committee, and I am honored to welcome the 2012 awardees into a family of scientists eager to share ideas and to collaborate for years to come."

The program is rigorously competitive, and recipients receive $240,000 over four years to pursue their research without restriction. To be considered, applicants from all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 179 institutions were requested to nominate a candidate, and 134 eligible nominations were received.

The initiative is run by The Pew Charitable Trusts, which also directs the Pew Latin American Fellows in the Biomedical Sciences, a program that for 21 years has provided support for young scientists from Latin America to receive postdoctoral training in the United States.

The new 2012 Pew Scholars are:

Dinu Florin Albeanu, Ph.D.
Cold Spring Harbor Laboratory
Neuroscience

Peter V. Cornish, Ph.D.
University of Missouri
Biochemistry and Biophysics

Maximiliano A. D'Angelo, Ph.D.
University of California, San Francisco
Cell Biology

D. Allan Drummond, Ph.D.
University of Chicago
Biochemistry and Molecular Biology

Nels C. Elde, Ph.D.
University of Utah
Evolutionary Genetics, Cell Biology

Donald Fox, Ph.D.
Duke University Medical Center
Tissue Repair and Genome Stability

Robert C. Froemke, Ph.D.
Skirball Institute, New York University
School of Medicine
Neuroscience

Wolfram Goessling, M.D., Ph.D.
Dana-Farber Cancer Institute
Developmental and Regenerative Biology

Xue Han, Ph.D.
Boston University
Neuroscience

Ivaylo I. Ivanov, Ph.D.
Columbia University Medical Center
Immunology

Salil A. Lachke, Ph.D.
University of Delaware
Developmental Genetics

Saskia B. Neher, Ph.D.
University of North Carolina, Chapel Hill
Protein Biochemistry

Lorin E. Olson, Ph.D.
Oklahoma Medical Research Foundation Developmental and Regenerative Biology

Kevin K. Park, Ph.D.
University of Miami Miller School of Medicine
Neuroscience

Sohini Ramachandran, Ph.D.
Brown University
Human Genomics and Evolution

Vanessa Ruta, Ph.D.
The Rockefeller University
Neuroscience

Aimee Shen, Ph.D.
University of Vermont
Microbiology

Alexander Sher, Ph.D.
University of California, Santa Cruz
Neuroscience

Alexander V. Statsuk, Ph.D.
Northwestern University
Chemical Biology

Kathryn E. Wellen, Ph.D.
University of Pennsylvania
Cancer Metabolism and Epigenetics

Mee-Ngan F. Yap, Ph.D.
Saint Louis University
Molecular Microbiology

Wenjun Zhang, Ph.D.
University of California, Berkeley
Chemical and Synthetic Biology


'/>"/>

Contact: Nicolle Grayson
ngrayson@pewtrusts.org
202-540-6347
Pew Health Group
Source:Eurekalert

Related biology news :

1. First complete full genetic map of promising energy crop
2. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
3. Promising developments in early diagnosis and treatment of mesothelioma
4. Ultrasensitive biosensor promising for medical diagnostics
5. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
6. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
7. Queens scientists seek vaccine for Pseudomonas infection
8. Scientists produce eye structures from human blood-derived stem cells
9. American Society of Plant Biologists honors early career women scientists
10. Brandeis scientists win prestigious prize for circadian rhythms research
11. Scientists discover new method of proton transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ... 23, 2017 , ... BellBrook Labs is formalizing a significant ... of biochemical analyses critical for Lead Discovery. The company’s Lead Discovery Services ... including inhibitor potency and selectivity, mechanism of action, and inhibitor residence times on ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)...  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, parks ... head lice treatment salon to set up shop. But there,s ... a French bistro on E Madison Ave, and CEO ... old lice clinic, we pride ourselves on being a destination ... of the stigma associated with lice. Everyone can get lice ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® ... adults at home or in healthcare facilities during periods of rest. A lightweight, ...
Breaking Biology Technology: